Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,602 stories, page 403 of 677

Advanced search

🇺🇰Jul 28Industrygsk.comTier 1 · Company source

GSK’s licensor Hansoh Pharma announces positive results from a second phase III trial for Ris-Rez in China

GSK NewsOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Atea's 8-week hepatitis C regimen posts 93.5% cure rate

Stock TitanOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Grace Therapeutics Advances Second U.S. Manufacturing Route for GTx-104

Stock TitanOriginal source

🇺🇸Jul 28Devicesir.idexx.comTier 1 · Company source

IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals

IDEXX LaboratoriesOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Insiders In Kane Biotech Still Down 40% On CA$1.70m Investment

simplywall.stOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Sihuan Pharmaceutical Holdings Group (SEHK:460) Looks Pricey On 2026 Earnings Guidance

simplywall.stOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

China's biotech rise to face challenges from US policy responses

The Pharma LetterOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Singapore: HST Medical acquired by Kowa Pharmaceutical Asia to scale health brands globally

Investors in HealthcareOriginal source

🌍Jul 28discoverynews.google.comTier 2 · Trade media

Preliminary trial results suggest a path to a safer Alzheimer’s treatment

STATOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trial

NatureOriginal source

🇩🇪Jul 28Researchuni-heidelberg.deTier 2 · Direct publisher

The University Celebrates with Visitors from all Over the World

Heidelberg UniversityOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

SBI Securities Starts Takeda Pharmaceutical at Neutral with 5,400 Yen Price Target

marketscreener.comOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Parkinson’s Disease Drug Trial Extended Following Early Findings

Technology NetworksOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

HLB PEP registers antidiuretic hormone treatment ‘Vasopressin’ API with U.S. FDA

더바이오Original source

🌍Jul 28Industrysinopharmtech.comTier 1 · Company source

SinoPharmtech at the “Vysokiy Bereg 2026” Tourism Rally in Belarus

Sinopharm TechOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships

Macau BusinessOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Biotech Growth makes 14-times return on Forte Biosciences accepting $2.2bn bid from Argenx SE

QuotedDataOriginal source

🇮🇹Jul 28Researchhumanitas.itTier 2 · Direct publisher

Onde d’urto focali: applicazioni e benefici in ortopedia e riabilitazione

Humanitas Research HospitalOriginal source

🌍Jul 28discoverynews.google.comTier 2 · Trade media

From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD

STATOriginal source

🌍Jul 28Researchamref.orgTier 2 · Direct publisher

Feasibility of mainstreaming schistosomiasis and soil transmitted helminthiasis mass drug administration into primary healthcare: a baseline survey for a community case study in Western Kenya

Amref Health AfricaOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Kelun-Biotech receives trial notice for dual-payload ADC

Vietnam Investment Review - VIROriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Apnimed prepares IPO as Mass. biotechs near record year

The Business JournalsOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Hanmi Pharmaceutical posts Q2 profit surge on Lilly deal and strong Korea sales - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Hanmi Pharmaceutical Q2 Operating Profit Surges 116.9%

조선일보Original source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Poornima Restaurant, Iconic Fort Udupi Eatery, Loses Food Licence After Maharashtra FDA Finds Serious

LatestLYOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Gerresheimer doubles China injectable packaging capacity with new plant

Packaging InsightsOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

ABL Bio Wins Korea Approval for Phase 1 Trial of Bispecific Immuno-Oncology Drug ABL503

Seoul Economic DailyOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Natural beauty ingredients get biotech rebuild as crop scarcity rises

Personal Care InsightsOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

US pharma giant to pay out $7.9 billion over baby powder lawsuits

ABC News & Headlines – Australian Broadcasting CorporationOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Pacira Completes Manufacturing Transition in PCRX-201 Phase 2 Trial

The Clinical Trial VanguardOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Biotech Growth Trust Notes $2.2 Billion Acquisition Of Forte Biosciences

DirectorsTalk InterviewsOriginal source

🇫🇷Jul 28Researchchru-strasbourg.frTier 2 · Direct publisher

Journée mondiale de lutte contre les hépatites 2026 : les HUS franchissent une étape majeure vers l’objectif « zéro hépatite C »

Hôpitaux Universitaires de StrasbourgOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (WST) Is Down 6.0% After Raising 2026 Outlook and Expanding Daikyo Deal

simplywall.stOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

South Korea's FDA Sets First Concrete Clinical Trial Exemption Rules for Medical AI, Expands Special Provisions for Generative AI

finance.biggo.comOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Haisco Pharmaceutical Group Co. Ltd. Class A Revenue Breakdown – SZSE:002653

TradingViewOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

SLS Stock Hits 1-Month Low On China Arbitration Blow — Retail Bulls Call It A ‘Nothingburger’ Ahead Of AML Readout

TradingViewOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

FDA Expert Panel Backs Compounding of Six Peptides

MedscapeOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

FDA Expert Panel Backs Compounding of Six Peptides

MedscapeOriginal source

🌍Jul 28Industryabelzeta.comTier 1 · Company source

AbelZeta Receives FDA Clearance of Registrational Phase II Trial for C-CAR168 in Refractory Lupus Nephritis

AbelZeta PharmaOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

FDA suspends license of Mumbai’s six-decade-old Udupi eatery Poornima Restaurant

The Indian ExpressOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Sihuan Pharmaceutical Updates Bermuda Registered Office Address

The Globe and MailOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Aekyung Industrial and Dong Sung Pharmaceutical Collaborate with Fudan University on Dermatology and Beauty Research

Aju PressOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Viral Acne Removal Cream Brand Set to Launch IPO: A Breakthrough Moment for the Internet-Famous Skincare Label

36 KrOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Global Pharmaceutical Surfactants Market Size/Share Worth USD 6.93 Billion by 2035 at a 4.42% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Yahoo FinanceOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Sihuan Pharmaceutical Flags 217% Profit Surge on Medical Aesthetics and Portfolio Gains

The Globe and MailOriginal source

🇩🇰Jul 28Researchhealthsciences.ku.dkTier 2 · Direct publisher

Cancer patients are far more likely to develop mental disorder diagnoses

University of Copenhagen - HealthOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Interview: How Tragedy Changed the FDA

The Good Men ProjectOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

FDA Advisers Dismiss Safety Warnings, Back 4 Peptide Treatments

Dermatology AdvisorOriginal source

🌍Jul 28discoverynews.google.comTier 2 · Trade media

Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia

BioSpaceOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Using Compounded GLP-1 Drugs? Here's What Doctors Want You to Know

Health and MeOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Should Teva’s Branded-Drug Pivot and Duvakitug Bet Reshape How TEVA Investors View Earnings Power?

simplywall.stOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Argent BioPharma Finalizes US$5.5 Million CannEpil® Licensing Deal with Splash Beverage Group, Eliminates Major Debt

Kalkine MediaOriginal source

🌍Jul 28discoverynews.google.comTier 2 · Trade media

Otsuka to Present Pivotal Two-Year eGFR Results from the Phase 3 VISIONARY Trial of VOYXACT® (sibeprenlimab-szsi) in IgA Nephropathy (IgAN) at GlomCon Hawaii 2026

BioSpaceOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Selling US$5.8m Of Stock Was Lucrative Decision For Genscript Biotech Insiders

simplywall.stOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Study Examined The Effectiveness of Antibody Injection Simulations

LabrootsOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Yubo International Biotech Limited Revenue Breakdown – OTC:YBGJ

TradingViewOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Restricting illicit synthetic drugs a complicated challenge

fox23maine.comOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Bayer opens global innovation network to Korean biotech startups

koreabiomed.comOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

Hansoh Pharmaceutical Group Units Thailand Depositery Receipts Repr 0.01 Sh

TradingViewOriginal source

🌍Jul 28discoverynews.google.comTier 3 · Aggregated media

AriBio wraps up global phase 3 trial of AR1001, sets stage for topline results

koreabiomed.comOriginal source